real-world safety data of rituximab among mexican patients with neuromyelitis optica spectrum disorders

被引：0
|
作者：
Thomas, Domingo Coutinho [1 ]
Lopez, Yazmin Martinez [1 ]
Villanueva, Homero Alcocer [1 ]
Lopez, Sarai Rivera [1 ]
Gonzalez, Jose Gonzalez [1 ]
Vazquez, Teresita Corona [1 ]
Rivas, Veronica [1 ]
Rivera, Jose De Jesus Flores [1 ]
机构：
[1] Natl Inst Neurol & Neurosurg, Neurol Dept Demyelinating Disorders Clin, Mexico City, Mexico
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1680/3027
引用
收藏
页码：1127 / 1127
页数：1
相关论文
共 50 条
  • [41] Azathioprine for first-line treatment in neuromyelitis optica and neuromyelitis optica spectrum disorders: efficacy and safety
    Kim, J. H.
    Park, M. S.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 91 - 91
  • [42] VOIDING DYSFUNCTION IN PATIENTS WITH NEUROMYELITIS OPTICA SPECTRUM DISORDERS
    Gomes, Cristiano
    Carvalho, Fabricio
    Bissoli, Julio
    Bessa, Jose, Jr.
    Pereira, Samira
    Marchioli, Paulo
    Callegaro, Dagoberto
    Bruschini, Homero
    Srougi, Miguel
    NEUROUROLOGY AND URODYNAMICS, 2011, 30 (02) : 253 - 254
  • [43] Clinical and biochemical evaluation of rituximab as add on therapy in neuromyelitis optica spectrum disorders
    Ding, Chawen
    Zheng, Lei
    Xiong, Mingjian
    Zhang, Dongping
    Chen, Zhongmei
    Wang, Linge
    Luo, Zhihua
    Qiao, Hong
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2024,
  • [44] VOIDING DYSFUNCTION IN PATIENTS WITH NEUROMYELITIS OPTICA SPECTRUM DISORDERS
    Carvalho, Fabricio
    Gomes, Cristiano
    Pereira, Samira
    Bessa, Jose
    Bissoli, Julio, Jr.
    Callegaro, Dagoberto
    Marchiori, Paulo
    Bruschini, Homero
    Srougi, Miguel
    JOURNAL OF UROLOGY, 2011, 185 (04): : E605 - E605
  • [45] Survival in patients with neuromyelitis optica spectrum disorders: data from the Belgrade cohort
    Basuroski, I. Dujmovic
    Martinovic, V.
    Maric, G.
    Mesaros, S.
    Pekmezovic, T.
    Weinshenker, B.
    Drulovic, J.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 437 - 438
  • [46] Rituximab in Neuromyelitis Optica Spectrum Disorders: Why Not as First-Line Therapy
    Kim, Su-Hyun
    Kim, Ho Jin
    JAMA NEUROLOGY, 2017, 74 (04) : 482 - 482
  • [47] Experience with tocilizumab in patients with neuromyelitis optica spectrum disorders
    Carreon Guarnizo, E.
    Hernandez Clares, R.
    Castillo Trivino, T.
    Meca Lallana, V
    Arocas Casan, V
    Iniesta Martinez, F.
    Olascoaga Urtaza, J.
    Meca Lallana, J. E.
    NEUROLOGIA, 2022, 37 (03): : 178 - 183
  • [48] Evaluating the Economic Burden of Relapses in Neuromyelitis Optica Spectrum Disorder: A Real-World Analysis Using German Claims Data
    Rachel K. Knapp
    Fränce Hardtstock
    Thomas Wilke
    Ulf Maywald
    Barthold Deiters
    Sophie Schneider
    Julie Mouchet
    Neurology and Therapy, 2022, 11 : 247 - 263
  • [49] Voiding Dysfunction in Patients With Neuromyelitis Optica Spectrum Disorders
    de Carvalho, Fabricio Leite
    Gomes, Cristiano Mendes
    Apostolos-Pereira, Samira L.
    Bessa, Jose, Jr.
    Pinheiro, Marcello
    Marchiori, Paulo E.
    Bruschini, Homero
    Srougi, Miguel
    Callegaro, Dagoberto
    NEUROUROLOGY AND URODYNAMICS, 2016, 35 (01) : 39 - 43
  • [50] Autonomic Dysfunction in Patients with Neuromyelitis Optica Spectrum Disorders
    Kwon, Soonwook
    Kim, Ye Sel
    Kim, Juhyeon
    Seok, Jin Myoung
    Jung, Yun Shin
    Kim, Byoung Joon
    Min, Ju-Hong
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (03) : 478 - 478
12345